Geographical and socioeconomic differences in uptake of Pap test and mammography in Italy: results from the National Health Interview Survey

BMJ Open
Alessio PetrelliLidia Gargiulo

Abstract

The Italian National Health Service instituted cervical and breast cancer screening programmes in 1999; the local health authorities have a mandate to implement these screening programmes by inviting all women aged 25-64 years for a Pap test every 3 years (or for an Human Papilloma Virus (HPV) test every 5 years) and women aged 50-69 years for a mammography every 2 years. However, the implementation of screening programmes throughout the country is still incomplete. This study aims to: (1) describe cervical and breast cancer screening uptake and (2) evaluate geographical and individual socioeconomic difference in screening uptake. Data both from the Italian National Health Interview Survey (NHIS) conducted by the National Institute of Statistics in 2012-2013 and from the Italian National Centre for Screening Monitoring (INCSM) were used. The NHIS interviewed a national representative random sample of 32 831 women aged 25-64 years and of 16 459 women aged 50-69 years. Logistic multilevel models were used to estimate the effect of socioeconomic variables and behavioural factors (level 1) on screening uptake. Data on screening invitation coverage at the regional level, taken from INCSM, were used as ecological (level 2) covariates...Continue Reading

References

Jul 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G RoncoR Volante
Apr 1, 1998·Journal of the National Cancer Institute·M ZappaS Ciatto
Dec 13, 2003·Health Technology Assessment : HTA·C R BankheadJ Austoker
Jun 15, 2005·Cancer Causes & Control : CCC·Magdalena LagerlundMats Lambe
Jan 13, 2006·Social Science & Medicine·Ricardo Sabates, Leon Feinstein
Mar 21, 2006·BMC Health Services Research·Paolo Giorgi RossiAntonio Federici
Nov 21, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N PerryL von Karsa
Jun 5, 2008·International Journal of Public Health·Ricardo Sabates, Leon Feinstein
Jan 29, 2009·BMJ : British Medical Journal·Peter C GøtzscheKarsten Juhl Jørgensen
Apr 26, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D PulitiM Zappa
Jul 20, 2012·Journal of the National Cancer Institute·P AutierM Boniol
Oct 16, 2012·Preventive Medicine·E FerroniUNKNOWN Methods to increase participation Working Group
Oct 27, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Harmy Mohamed YusoffAmry Abdul Rahim
Sep 7, 2013·European Journal of Public Health·Barbara PacelliMaria P Fantini
Sep 16, 2015·European Journal of Public Health·A WoolsJ R J de Leeuw
Jun 12, 2016·Journal of Epidemiology and Community Health·Kavita VenkataramanChuen Seng Tan
Jun 16, 2017·Journal of Medical Screening·Paolo Giorgi RossiMarco Zappa
Sep 25, 2017·International Journal of Cancer. Journal International Du Cancer·Partha BasuRengaswamy Sankaranarayanan

❮ Previous
Next ❯

Citations

Jun 18, 2020·International Journal of Environmental Research and Public Health·Paolo Giorgi RossiAlessio Petrelli
Jun 27, 2019·Journal of Environmental and Public Health·Maria Teresa SchettinoEzgi Hanci Yenigün

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.